ABEVMY 100MG

Abevmy 100mg is a brand name of Bevacizumab, categorized as monoclonal anti-body & anti-angiogenesis
Abevmy 100mg is a combined human monoclonal antibody IgG1, that predicament to and prohibits the biological activity of human vascular endothelial growth factor (VEGF)

Bevacizumab

Abevmy

100mg

Mylan Pharma




INDICATION

Abevmy 100mg is used in the treatment of;
Metastatic colon or rectal cancer
In combination with 5-fluorouracil chemotherapy administered intravenously, first or second line drug of choice
Non-squamous, non-small cell lung cancer
Concurrent use with carboplatin and paclitaxel as first line therapy
Glioblastoma
Used in the treatment of recurrent Glioblastoma in adults
Metastatic renal cell cancer
Concurrent use with interferon alfa
Metastatic cervical cancer:
Concurrent use with paclitaxel & cisplatin or paclitaxel & topotecan
Epithelial ovarian, fallopian tube or peritoneal cancer:
In concomitant use with paclitaxel, pegylated liposomal doxorubicin or topotecan.

Mechanism of action

Abevmy 100mg comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells
This interaction prevents endothelial cell multiplication and new blood vessel production occurs
Thus in counts discontinuation of metastatic tumor cells growth happens.



ADME Properties

The pharmacokinetic form of Abevmy 100mg is assayed by measuring total serum Bevacizumab concentration.

The volume of distribution is 2.9 (22%) L

The terminal half-life period of Bevacizumab is 20days (11 to 50days)

Blueberrypharma.com-img1

drug
Brand Abevmy
Ingredients Bevacizumab
Strength 100mg/4ml
Manufactured Mylan Pharmaceuticals Ltd
Rating

Key point:
Abevmy do not administered before at least 28 days following surgery and the wound is completely cured
Metastatic colorectal carcinoma:
The prescribed dosage of Abevmy by concomitant with 5-fluorouracil based chemotherapy
5mg/kg of Abevmy for every 2 weeks IV in concomitant with bolus IFL
10mg/kg of Abevmy for every 2 weeks IV in combination with FOLFOX4
5mg/kg IV Abevmy for every 2 weeks or 7.5 mg/kg Abevmy as IV every 3 weeks by concurrently used with fluoropyrimidine Irinotecan or fluoropyrimidine oxaliplatin based therapy
Non-small cell lung cancer:
The recommended dosage of Abevmy is 15mg/kg IV for every 3 weeks by combining with carboplatin and paclitaxel
Glioblastoma:
10mg/kg of Abevmy administered IV for every 2 weeks
Metastatic renal cell cancer:
The prescribed dosage of Abevmy is 10mg/kg IV for every 2 weeks by concurrent use with interferon alfa
Metastatic cervical cancer:
The prescribed dosage of Abevmy; 15mg/kg of Abevmy given intravenously for every 3 weeks by combining with paclitaxel and cisplatin or with paclitaxel and topotecan
Epithelial ovarian, fallopian tube or peritoneal cancer:
Platinum opposing: The recommended dosage of Abevmy; 10mg/kg of Abevmy for every 2 weeks by concurrent use with paclitaxel, pegylated liposomal doxorubicin or topotecan
Or The recommended dosage of Abevmy; 15mg/kg of Abevmy given through IV for every 3 weeks by combining with topotecan Platinum responsive
The recommended dosage of Abevmy; 15mg/kg given IV for 3 weeks in concomitant with carboplatin and paclitaxel for 6 to 8 cycles
The recommended dosage of Abevmy; 15mg/kg of Abevmy given IV for 3 weeks by combining with gemcitabine & carboplatin for 6 to 10 cycles
Preparation & administration:
Abevmy is intravenous solution
At initial infusion: given IV infusion over 90 minutes
Following infusions: give second infusion over 60 minutes, if tolerated
Administer all following infusion over 30minutes
Abevmy IV infusion is prepared in aseptic condition
Abevmy 400mg containing 16ml solution whereas 100mg containing 4ml
Abevmy dilute into 100ml of 0.9% NS
Do not dilute with dextrose solution
Discard the remaining portion which is left in a vial.

Gastrointestinal perforation and fistulae
Surgery and wound healing complication
Hemorrhage
Arterial thromboembolic events
Venous thromboembolic events
Hypertension
Posterior reversible encephalopathy syndrome
Renal injury & Proteinuria
Infusion reactions
Ovarian failure
Congestive heart failure
Neutropenia, mucosal inflammation, infection, neuropathy, Epistaxis, erythrodysesthesia.

Caution with use in the conditions like;
While using Abevmy 100mg these are some complications occurred during therapy, care should be taken
Hypertension
Posterior reversible encephalopathy syndrome
Gastrointestinal perforations
Wound healing complications
Hemorrhage
Arterial thromboembolic events
Venous thromboembolic events
Embryo fetal toxicity occurs.

DRUG – DRUG INTERACTION

  • While administering Abevmy 100mg with paclitaxel & carboplatin, causes decrease in exposure of paclitaxel after four cycles of therapy
  • While getting patients with paclitaxel & carboplatin leads to increase the paclitaxel exposure at day 6

Contraindications

No contraindication occurred



Pregnancy category: D
Abevmy 100mg should not be used in pregnancy condition

Breast feeding is also not recommended

Abevmy 100mg vial should be stored at 2 to 8°C (36 to 46°F) Single use vial.

If patient fail to take the dose or missed the cycle means must consult with oncologist and follow the regular dosing schedule Do not take overdose

Blueberrypharma.com-img2



Quick Contact




Prescription upload






PRESCRIPTION


Blueberrypharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Blueberrypharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Blueberrypharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Blueberrypharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Blueberrypharma.com

At Blueberrypharma.com , a Caregiver can order prescription medicines on your behalf.